Equities research analysts expect that Azenta, Inc. (NASDAQ:AZTA – Get Rating) will announce $0.10 earnings per share for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Azenta’s earnings. The highest EPS estimate is $0.12 and the lowest is $0.07. Azenta posted earnings of $0.79 per share during the same quarter last year, which indicates a negative year over year growth rate of 87.3%. The business is expected to report its next quarterly earnings results on Monday, January 1st.
According to Zacks, analysts expect that Azenta will report full year earnings of $0.53 per share for the current financial year, with EPS estimates ranging from $0.40 to $0.62. For the next year, analysts anticipate that the firm will post earnings of $0.98 per share, with EPS estimates ranging from $0.78 to $1.15. Zacks’ earnings per share averages are a mean average based on a survey of analysts that follow Azenta.
Azenta (NASDAQ:AZTA – Get Rating) last issued its quarterly earnings results on Monday, May 9th. The company reported $0.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.11 by $0.01. Azenta had a net margin of 301.05% and a return on equity of 4.28%. The company had revenue of $145.60 million during the quarter, compared to the consensus estimate of $142.10 million. During the same quarter in the previous year, the firm earned $0.61 earnings per share. The firm’s quarterly revenue was up 12.3% on a year-over-year basis.
Azenta stock traded down $0.71 during trading on Friday, reaching $69.55. The stock had a trading volume of 15,778 shares, compared to its average volume of 626,452. Azenta has a 52-week low of $61.35 and a 52-week high of $124.79. The firm has a 50 day moving average of $78.87. The stock has a market capitalization of $5.22 billion, a PE ratio of 2.34 and a beta of 1.66.
Azenta Company Profile (Get Rating)
Azenta, Inc provides manufacturing automation solutions for the semiconductor industry, and life science sample-based services and solutions for the life sciences market worldwide. The company operates in two segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated ultra-cold storage systems and consumables, including racks, tubes, caps, plates, and foils; instruments, such as labeling, bar coding, capping, de-capping, auditing, sealing, peeling, piercing tubes, and plates.
- Get a free copy of the StockNews.com research report on Azenta (AZTA)
- 3 Retailers That Defied First Quarter Headwinds
- Will John Deere’s Earnings Help to Calm the Markets?
- Rapid7: Could Be Profitable in FY 2022 Despite Bear Market
- Lowe’s Companies Has Not Bottomed
- Silicon Labs Stock is Falling to a Better Place
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.